User menu

Human skin fibroblasts: From mesodermal to hepatocyte-like differentiation.

Bibliographic reference Lysy, Philippe ; Smets, Françoise ; Sibille, Catherine ; Najimi, Mustapha ; Sokal, Etienne. Human skin fibroblasts: From mesodermal to hepatocyte-like differentiation.. In: Hepatology (Baltimore, Md.), Vol. 46, no. 5, p. 1574-85 (2007)
Permanent URL http://hdl.handle.net/2078.1/11172
  1. El-Serag Hashem B., Hepatocellular Carcinoma, 10.1056/nejmra1001683
  2. Mazzaferro Vincenzo, Regalia Enrico, Doci Roberto, Andreola Salvatore, Pulvirenti Andrea, Bozzetti Federico, Montalto Fabrizio, Ammatuna Mario, Morabito Alberto, Gennari Leandro, Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis, 10.1056/nejm199603143341104
  3. Massie A. B., Caffo B., Gentry S. E., Hall E. C., Axelrod D. A., Lentine K. L., Schnitzler M. A., Gheorghian A., Salvalaggio P. R., Segev D. L., MELD Exceptions and Rates of Waiting List Outcomes : MELD Exceptions and Rates of Waiting List Outcomes, 10.1111/j.1600-6143.2011.03735.x
  4. Salgia Reena J., Goodrich Nathan P., Marrero Jorge A., Volk Michael L., Donor Factors Similarly Impact Survival Outcome After Liver Transplantation in Hepatocellular Carcinoma and Non-hepatocellular Carcinoma Patients, 10.1007/s10620-013-2883-7
  5. Kim W. R., Smith J. M., Skeans M. A., Schladt D. P., Schnitzler M. A., Edwards E. B., Harper A. M., Wainright J. L., Snyder J. J., Israni A. K., Kasiske B. L., OPTN/SRTR 2012 Annual Data Report: Liver : OPTN & SRTR Annual Data Report 2012, 10.1111/ajt.12581
  6. Prasad K. Raj, Young Richard S., Burra Patrizia, Zheng Shu-Sen, Mazzaferro Vincenzo, Bog Moon Duk, Freeman Richard B., Summary of candidate selection and expanded criteria for liver transplantation for hepatocellular carcinoma: A review and consensus statement, 10.1002/lt.22380
  7. Yao F. Y., Liver Transplantation for Hepatocellular Carcinoma: Beyond the Milan Criteria, 10.1111/j.1600-6143.2008.02351.x
  8. Bittermann T., Niu B., Hoteit M. A., Goldberg D., Waitlist Priority for Hepatocellular Carcinoma Beyond Milan Criteria: A Potentially Appropriate Decision Without a Structured Approach : Exception Points in HCC Beyond Milan Criteria, 10.1111/ajt.12530
  9. Mehta, Liver Transpl, 19, 1055 (2013)
  10. Roberts John P., Venook Alan, Kerlan Robert, Yao Francis, Hepatocellular carcinoma: Ablate and wait versus rapid transplantation, 10.1002/lt.22103
  11. Duvoux Christophe, Roudot–Thoraval Françoise, Decaens Thomas, Pessione Fabienne, Badran Hanaa, Piardi Tullio, Francoz Claire, Compagnon Philippe, Vanlemmens Claire, Dumortier Jérome, Dharancy Sébastien, Gugenheim Jean, Bernard Pierre–Henri, Adam René, Radenne Sylvie, Muscari Fabrice, Conti Filomena, Hardwigsen Jean, Pageaux Georges–Philippe, Chazouillères Olivier, Salame Ephrem, Hilleret Marie–Noelle, Lebray Pascal, Abergel Armand, Debette–Gratien Marilyne, Kluger Michael D., Mallat Ariane, Azoulay Daniel, Cherqui Daniel, Liver Transplantation for Hepatocellular Carcinoma: A Model Including α-Fetoprotein Improves the Performance of Milan Criteria, 10.1053/j.gastro.2012.05.052
  12. Hameed Bilal, Mehta Neil, Sapisochin Gonzalo, Roberts John P., Yao Francis Y., Alpha-fetoprotein level > 1000 ng/mL as an exclusion criterion for liver transplantation in patients with hepatocellular carcinoma meeting the Milan criteria : Alpha-Fetoprotein and Liver Transplant for HCC, 10.1002/lt.23904
  13. Otto Gerd, Herber Sascha, Heise Michael, Lohse Ansgar W., Mönch Christian, Bittinger Fernando, Hoppe-Lotichius Maria, Schuchmann Marcus, Victor Anja, Pitton Michael, Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma, 10.1002/lt.20837
  14. Millonig Gunda, Graziadei Ivo W., Freund Martin C., Jaschke Werner, Stadlmann Sylvia, Ladurner Ruth, Margreiter Raimund, Vogel Wolfgang, Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma, 10.1002/lt.21033
  15. Lai, Liver Transpl, 19, 1108 (2013)
  16. Thomas Melanie B., Jaffe Deborah, Choti Michael M., Belghiti Jacques, Curley Steven, Fong Yuman, Gores Gregory, Kerlan Robert, Merle Phillipe, O'Neil Bert, Poon Ronnie, Schwartz Lawrence, Tepper Joel, Yao Francis, Haller Daniel, Mooney Margaret, Venook Alan, Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting, 10.1200/jco.2010.28.7805
  17. Pomfret Elizabeth A., Washburn Kenneth, Wald Christoph, Nalesnik Michael A., Douglas David, Russo Mark, Roberts John, Reich David J., Schwartz Myron E., Mieles Luis, Lee Fred T., Florman Sander, Yao Francis, Harper Ann, Edwards Erick, Freeman Richard, Lake John, Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States, 10.1002/lt.21999
  18. Bruix Jordi, Sherman Morris, Management of hepatocellular carcinoma, 10.1002/hep.20933
  19. , , EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma, 10.1016/j.jhep.2011.12.001
  20. Mitchell Donald G., Bruix Jordi, Sherman Morris, Sirlin Claude B., LI-RADS (Liver Imaging Reporting and Data System): Summary, discussion, and consensus of the LI-RADS Management Working Group and future directions, 10.1002/hep.27304
  21. Wald Christoph, Russo Mark W., Heimbach Julie K., Hussain Hero K., Pomfret Elizabeth A., Bruix Jordi, New OPTN/UNOS Policy for Liver Transplant Allocation: Standardization of Liver Imaging, Diagnosis, Classification, and Reporting of Hepatocellular Carcinoma, 10.1148/radiol.12121698
  22. Yao Francis Y., Breitenstein Stefan, Broelsch Christoph E., Dufour Jean-Francois, Sherman Morris, Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma?, 10.1002/lt.22335
  23. Bruix Jordi, Sherman Morris, Llovet Josep M, Beaugrand Michel, Lencioni Riccardo, Burroughs Andrew K, Christensen Erik, Pagliaro Luigi, Colombo Massimo, Rodés Juan, Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference, 10.1016/s0168-8278(01)00130-1
  24. Lencioni Riccardo, Llovet Josep, Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma, 10.1055/s-0030-1247132
  25. Shetty Kirti, Timmins Kate, Brensinger Colleen, Furth Emma E., Rattan Sushil, Sun Weijing, Rosen Mark, Soulen Michael, Shaked Abraham, Reddy K. Rajender, Olthoff Kim M., Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome, 10.1002/lt.20140
  26. Lo ChungMau, Downstaging of Hepatocellular Carcinoma Before Transplantation: An Advance in Therapy or Just Another Selection Criterion, 10.1111/j.1600-6143.2008.02466.x
  27. Majno Pietro E., Adam René, Bismuth Henri, Castaing Denis, Ariche Arie, Krissat Jinane, Perrin Hubert, Azoulay Daniel, Influence of Preoperative Transarterial Lipiodol Chemoembolization on Resection and Transplantation for Hepatocellular Carcinoma in Patients With Cirrhosis : , 10.1097/00000658-199712000-00006
  28. Graziadei I, Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome, 10.1053/jlts.2003.50106
  29. Chapman, Ann Surg, 248, 617 (2008)
  30. Yao Francis Y., Kerlan Robert K., Hirose Ryutaro, Davern Timothy J., Bass Nathan M., Feng Sandy, Peters Marion, Terrault Norah, Freise Chris E., Ascher Nancy L., Roberts John P., Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: An intention-to-treat analysis, 10.1002/hep.22412
  31. Ravaioli M., Grazi G. L., Piscaglia F., Trevisani F., Cescon M., Ercolani G., Vivarelli M., Golfieri R., D'Errico Grigioni A., Panzini I., Morelli C., Bernardi M., Bolondi L., Pinna A. D., Liver Transplantation for Hepatocellular Carcinoma: Results of Down-Staging in Patients Initially Outside the Milan Selection Criteria, 10.1111/j.1600-6143.2008.02409.x
  32. De Luna W., Sze D. Y., Ahmed A., Ha B. Y., Ayoub W., Keeffe E. B., Cooper A., Esquivel C., Nguyen M. H., Transarterial Chemoinfusion for Hepatocellular Carcinoma as Downstaging Therapy and a Bridge toward Liver Transplantation, 10.1111/j.1600-6143.2009.02576.x
  33. Lewandowski R. J., Kulik L. M., Riaz A., Senthilnathan S., Mulcahy M. F., Ryu R. K., Ibrahim S. M., Sato K. T., Baker T., Miller F. H., Omary R., Abecassis M., Salem R., A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization, 10.1111/j.1600-6143.2009.02695.x
  34. JANG J. W., YOU C. R., KIM C. W., BAE S. H., YOON S. K., YOO Y. K., KIM D. G., CHOI J. Y., Benefit of downsizing hepatocellular carcinoma in a liver transplant population, 10.1111/j.1365-2036.2009.04167.x
  35. Barakat, Liver Transpl, 16, 289 (2010)
  36. Green Tyler J., Rochon Paul J., Chang Samuel, Ray Charles E., Winston Helena, Ruef Robert, Kreidler Sarah M., Glueck Deborah H., Shulman Benjamin C., Brown Anthony C., Durham Janette, Downstaging Disease in Patients with Hepatocellular Carcinoma Outside of Milan Criteria: Strategies Using Drug-eluting Bead Chemoembolization, 10.1016/j.jvir.2013.07.024
  37. Yao Francis Y., Mehta Neil, Flemming Jennifer, Dodge Jennifer, Hameed Bilal, Fix Oren, Hirose Ryutaro, Fidelman Nicholas, Kerlan Robert K., Roberts John P., Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria : HEPATOLOGY, Vol. XX, No. X, 2015, 10.1002/hep.27752
  38. Clavien Pierre-Alain, Lesurtel Mickael, Bossuyt Patrick MM, Gores Gregory J, Langer Bernard, Perrier Arnaud, Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report, 10.1016/s1470-2045(11)70175-9
  39. Lammer Johannes, , Malagari Katarina, Vogl Thomas, Pilleul Frank, Denys Alban, Watkinson Anthony, Pitton Michael, Sergent Geraldine, Pfammatter Thomas, Terraz Sylvain, Benhamou Yves, Avajon Yves, Gruenberger Thomas, Pomoni Maria, Langenberger Herbert, Schuchmann Marcus, Dumortier Jerome, Mueller Christian, Chevallier Patrick, Lencioni Riccardo, Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study, 10.1007/s00270-009-9711-7
  40. Goin James E., Salem Riad, Carr Brian I., Dancey Janet E., Soulen Michael C., Geschwind Jean-Francois H., Goin Kathleen, Van Buskirk Mark, Thurston Kenneth, Treatment of Unresectable Hepatocellular Carcinoma with Intrahepatic Yttrium 90 Microspheres: A Risk-Stratification Analysis, 10.1097/01.rvi.0000142602.79459.90
  41. Garwood Elisabeth R., Fidelman Nicholas, Hoch Sarah E., Kerlan Robert K., Yao Francis Y., Morbidity and mortality following transarterial liver chemoembolization in patients with hepatocellular carcinoma and synthetic hepatic dysfunction : High-Risk Transarterial Chemoembolization Outcomes, 10.1002/lt.23552
  42. Sieghart Wolfgang, Hucke Florian, Pinter Matthias, Graziadei Ivo, Vogel Wolfgang, Müller Christian, Heinzl Harald, Trauner Michael, Peck-Radosavljevic Markus, The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma, 10.1002/hep.26256
  43. Terzi Eleonora, Terenzi Laura, Venerandi Laura, Croci Luca, Renzulli Matteo, Mosconi Cristina, Allegretti Giulia, Granito Alessandro, Golfieri Rita, Bolondi Luigi, Piscaglia Fabio, , The ART Score Is Not Effective to Select Patients for Transarterial Chemoembolization Retreatment in an Italian Series, 10.1159/000368007
  44. Kwan Sharon W., Fidelman Nicholas, Ma Elizabeth, Kerlan Robert K., Yao Francis Y., Imaging predictors of the response to transarterial chemoembolization in patients with hepatocellular carcinoma: A radiological-pathological correlation, 10.1002/lt.23413
  45. Mehta Neil, Dodge Jennifer L., Goel Aparna, Roberts John Paul, Hirose Ryutaro, Yao Francis Y., Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: Implications for the current organ allocation policy : HCC and Wait-List Dropout, 10.1002/lt.23753
  46. Hakeem, Aliment Pharmacol Ther, 35, 987 (2012)
  47. Mehta Neil, Fidelman Nicholas, Sarkar Monika, Yao Francis Y., Factors Associated With Outcomes and Response to Therapy in Patients With Infiltrative Hepatocellular Carcinoma, 10.1016/j.cgh.2012.12.030
  48. Toso C., Mentha G., Majno P., Liver Transplantation for Hepatocellular Carcinoma: Five Steps to Prevent Recurrence : Liver Transplantation for HCC, 10.1111/j.1600-6143.2011.03689.x
  49. Mehta, Hepatology, 60, 253A (2014)